Margaret A. Alexander - 09 Sep 2024 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
President and COO
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
OVID
Transactions as of
09 Sep 2024
Net transactions value
$0
Form type
4
Filing time
11 Sep 2024, 17:38:01 UTC
Next filing
29 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OVID Employee Stock Option (right to buy) Award $0 +140,000 $0.000000 140,000 09 Sep 2024 Common Stock 140,000 $1.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the Stock Option will vest and become exercisable on September 9, 2025 and the remaining shares will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued services through such date.